Saturday, November 14, 2020 8:04:47 AM
Recent BRTX News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 12/05/2024 10:37:59 PM
- BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem® Metabolic Disease Program • GlobeNewswire Inc. • 12/05/2024 11:45:00 AM
- BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data • GlobeNewswire Inc. • 11/13/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:15:39 PM
- BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/12/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2024 09:43:22 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/06/2024 09:37:48 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 11/06/2024 09:25:26 PM
- BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research Symposium • GlobeNewswire Inc. • 11/06/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/05/2024 09:33:45 PM
- BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health • GlobeNewswire Inc. • 11/05/2024 12:10:00 PM
- BioRestorative Therapies Receives Patent Allowance for ThermoStem® Metabolic Disease Program • GlobeNewswire Inc. • 10/31/2024 11:00:00 AM
- BioRestorative Therapies to Participate in Upcoming UBS and Maxim Group Investor Events • GlobeNewswire Inc. • 10/10/2024 11:00:00 AM
- BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference • GlobeNewswire Inc. • 10/03/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 08:33:16 PM
- BioRestorative Therapies’ IFATS 2024 Presentation to Feature ThermoStem® Platform’s Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 Drugs • GlobeNewswire Inc. • 09/19/2024 10:55:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:30:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:11:03 PM
- BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/13/2024 08:05:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/08/2024 08:23:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:47:26 PM
- BioRestorative Therapies to Report Second Quarter 2024 Financial Results and Host Conference Call on August 13, 2024 • GlobeNewswire Inc. • 08/06/2024 08:05:00 PM
- BioRestorative Therapies’ Chief Scientist Named New Section Editor of the Prestigious Journal of Translational Medicine • GlobeNewswire Inc. • 07/23/2024 11:10:00 AM
- BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program • GlobeNewswire Inc. • 06/27/2024 11:40:00 AM
FEATURED Cannabix Technologies Announces Key Hardware Advancements to Marijuana Breathalyzer Technology • Jan 9, 2025 8:49 AM
UAV Corp. (UMAV) Further Reduces Authorized Shares to 500 Million • UMAV • Jan 8, 2025 2:27 PM
Fifty 1 Labs, Inc. Launches Dedicated Website for Shareholders and Investors, Company now current with OTC Markets • CAFI • Jan 7, 2025 9:00 AM
EzFill Holdings, Inc. Successfully Closes Acquisition of Shell Fleet, Accelerating Nationwide Mobile Fueling Expansion • EZFL • Jan 7, 2025 8:35 AM
CGRA Signs Binding Term Sheet to Merge With American Infrastructure Corporation, a Subsidiary of Nasdaq-listed American Resources Corporation (Nasdaq: AREC) • CGRA • Jan 6, 2025 10:31 AM
UAV Corp (UMAV) Working on Securing $1.5 Billion in Contracts and Announces Groundbreaking Partnership with Atlantic Industrial Group • UMAV • Jan 6, 2025 9:26 AM